William Pao On Pfizer’s ‘Aspirational’ Drug Development Goal, Seagen And More

R&D Leader Met With Scrip At New Headquarters

 
• By Jessica Merrill
  
William Pao, M.D., Ph.D., is Chief Development Officer and Executive Vice President for Pfizer
Pfizer's William Pao • Source: Pfizer
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip